MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Coat test: a bedside timed test for quantifying motor function in Parkinson’s disease patients.

    C. Holgado, M. Wilken, G. Lopez, M. Merello (Buenos Aires, Argentina)

    Objective: To develop  a bedside  quantitative test for evaluating motor affectation  in patients with Parkinson's Disease. Background: The MDS-UPDRS part III is still the most…
  • 2024 International Congress

    Managing Cognitive Decline in Vascular Dementia with Associated Parkinsonism

    J. Hall, R. Islam, C. Rowan, B. Carr (GAINESVILLE, USA)

    Objective: The intersection of vascular dementia (VaD) and secondary parkinsonism presents a complex therapeutic conundrum, particularly in geriatric populations. This study aims to elucidate the…
  • 2024 International Congress

    Subthalamic Nucleus Stimulation Modulates Cognitive Theory of Mind in Parkinson’s Disease

    HY. Xiao, LQ. Lang, Z. Ye, JJ. Wu (Shanghai, China)

    Objective: This study aims to investigate the effect of subthalamic nucleus (STN) deep brain stimulation (DBS) on ToM using the Parkinson’s disease (PD) model. Background:…
  • 2024 International Congress

    Frontal dysfunction as a cognitive biomarker in prodromal Parkinson’s disease

    SJM. Jesús Maestre, LMD. Muñoz Delgado, ACG. Castellano Guerrero, MSE. San Eufrasio, AAG. Adarmes Gómez, DMG. Macías García, PFR. Franco Rosado, BV. Villarreal, BB. Benitez, CPC. Perez Calvo, FCG. Carrillo García, JMR. Martín Rodríguez, PMR. Mir Rivera (SEVILLA, Spain)

    Objective: To assess specific cognitive biomarkers to increase the sensibility for the diagnosis of Prodromal Parkinson’s disease (pPD) that could help to identify these patients.…
  • 2024 International Congress

    Neuropsychological Predictors of Cognitive Decline in Parkinson’s Disease: A Systematic Review (PDCogniCare)

    D. Pourzinal, K. Sivakumaran, J. Yang, D. Bailey, L. Mitchell, D. Brooks, A. Lehn, J. Liddle, N. Pachana, H. Tinson, K. Shrubsole, N. Dissanayaka (Herston, Australia)

    Objective: This systematic review aimed to synthesise current neuropsychological predictors of cognitive decline in Parkinson's disease (PD). Background: The observed heterogeneity of cognitive function in…
  • 2024 International Congress

    Dual Frequency Stimulation of the Subthalamic Nucleus Improves Emotional State in Parkinson’s Disease

    E. Pegolo, F. Cucinotta, I. Hossain, B. Ishihara, M. Hart, E. Pereira, F. Morgante, A. Fasano, L. Ricciardi (Padova, Italy)

    Objective: To evaluate the effect on emotional states of dual frequency STN-DBS (high frequency + low frequency) as compared to high frequency or low frequency…
  • 2024 International Congress

    A Network Analysis shows How Impulsive-Compulsive Behaviors correlates with Levodopa-Induced Dyskinesia

    B. Veiga, C. Silva, S. Silva, R. Saba, H. Ferraz, V. Borges (São Paulo, Brazil)

    Objective: To study Impulsive Compulsive Behaviors (ICBs) and Levodopa-Induced Dyskinesias (LIDs) in Young Onset Parkinson's disease (YOPD) patients. Background: Parkinson's disease (PD) is a neurodegenerative…
  • 2024 International Congress

    Decoding Fatigue in Parkinson’s Disease: Exploring Multifactorial Associations

    F. Sarmento, G. Lamp, V. Srikar Lavu, A. S. Madamangalam, J. K. Wong (Gainesville, USA)

    Objective: To examine the relationship between fatigue, clinical demographics and NMS in PD patients to inform targeted treatment approaches. Background: Non-motor symptoms (NMS) in Parkinson’s…
  • 2024 International Congress

    Prodromal Parkinson’s disease in the general population

    G. de Klerk, T. van Laar, S. Meles (Groningen, Netherlands)

    Objective: To investigate the diagnostic value of the MDS research criteria for the detection of the prodromal phase of Parkinson’s disease (PD) in the general…
  • 2024 International Congress

    Prodromal RBD and the risk of cognitive impairment in Parkinson’s disease.

    A. Martinez-Nunez, H. Hutchinson, V. Lavu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesvile, USA)

    Objective: To identify the impact of prodromal RBD in the incidence of cognitive impairment in patients with early PD. Background: The association between sleep disorders…
  • « Previous Page
  • 1
  • …
  • 124
  • 125
  • 126
  • 127
  • 128
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley